Ani Pharmaceuticals (ANIP) Interest Coverage Ratio (2011 - 2013)
Ani Pharmaceuticals' (ANIP) quarterly Interest Coverage Ratio came in at 35306.12 in Q4 2013, up 305308.43% year-over-year from N/an in Q4 2012, and up 350332.99% quarter-over-quarter from 10.08 in Q2 2013.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Interest Coverage Ratio (2011 - 2013) Analysis & Trends
Ani Pharmaceuticals has disclosed Interest Coverage Ratio across 3 years of filings, most recently posting 35306.12 for Q4 2013.
- In Q4 2013, Interest Coverage Ratio rose 305308.43% year-over-year to 35306.12; the TTM figure through Mar 2014 stood at 10.65 (up 3568.31% YoY), while the FY2013 annual figure was 1.92, up 6175.49% from the prior year.
- Interest Coverage Ratio came in at 35306.12 for Q4 2013 at Ani Pharmaceuticals, up from 10.08 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 35306.12 in Q4 2013 to a low of 73.03 in Q3 2011.
- Average Interest Coverage Ratio over 3 years is 4396.9, with a median of 6.32 recorded in 2013.
- The largest YoY upside for Interest Coverage Ratio was 305308.43% in 2013 against a maximum downside of 961.23% in 2013.
- Over 3 years, Interest Coverage Ratio stood at 39.16 in 2011, then soared by 70.46% to 11.57 in 2012, then soared by 305308.43% to 35306.12 in 2013.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 35306.12 in Q4 2013, 10.08 in Q2 2013, and 4.33 in Q1 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 579.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 35,306.12 |
| Jun 30, 2013 | -10.08 |
| Mar 31, 2013 | 4.33 |
| Dec 31, 2012 | -11.57 |
| Sep 30, 2012 | -2.55 |
| Jun 30, 2012 | 1.17 |
| Dec 31, 2011 | -39.16 |
| Sep 30, 2011 | -73.03 |